Nintedanib E-Isomer | CAS 1160294-26-7 - Request Quote
Nintedanib E-Isomer
| SZ CAT No: | SZ-N023003 |
| CAS No | 1160294-26-7 |
| Mol.F. | C31H33N5O4 |
| Mol.Wt. | 539.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Nintedanib E-Isomer is chemically Methyl (E)-3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate. Nintedanib E-Isomer is supplied with detailed characterization data compliant with regulatory guideline. Nintedanib E-Isomer can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nintedanib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1160294-26-7
Purchase 1160294-26-7
Order 1160294-26-7
Enquire 1160294-26-7
price of 1160294-26-7
1160294-26-7 Supplier
1160294-26-7 Manufacturer
1160294-26-7 Exporter
buy high quality Nintedanib E-Isomer
Purchase Nintedanib E-Isomer
Nintedanib E-Isomer suppliers
Nintedanib E-Isomer manufacturers
Nintedanib E-Isomer price
Order Nintedanib E-Isomer
Enquire Nintedanib E-Isomer
Nintedanib E-Isomer cost
Nintedanib E-Isomer Supplier
Nintedanib E-Isomer Distributor
Nintedanib E-Isomer for Method Validation
Nintedanib Reference Standard
Nintedanib E-Isomer for ANDA Filing
Nintedanib E-Isomer for Forced Degradation Studies
Nintedanib E-Isomer Identification Standards
Nintedanib E-Isomer for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


